These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29454848)

  • 21. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.
    Skoutelis A; Pefanis A; Tsiodras S; Sipsas NV; Lelekis M; Lazanas MC; Gargalianos P; Dalekos GN; Roilides E; Samonis G; Maltezos E; Hatzigeorgiou D; Lada M; Metallidis S; Stoupis A; Chrysos G; Karnesis L; Symbardi S; Loupa CV; Giamarellou H; Kioumis I; Sambatakou H; Tsianos E; Kotsopoulou M; Georgopali A; Liakou K; Perlorentzou S; Levidiotou S; Giotsa-Toutouza M; Tsorlini-Christoforidou H; Karaiskos I; Kouppari G; Trikka-Graphakos E; Ntrivala MA; Themeli-Digalaki K; Pangalis A; Kachrimanidou M; Martsoukou M; Karapsias S; Panopoulou M; Maraki S; Orfanou A; Petinaki E; Orfanidou M; Baka V; Stylianakis A; Spiliopoulou I; Smilakou S; Zerva L; Vogiatzakis E; Belesiotou E; Gogos CA
    PLoS One; 2017; 12(8):e0182799. PubMed ID: 28813492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
    Pakyz AL; Jawahar R; Wang Q; Harpe SE
    J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comprehensive Assessment Across the Healthcare Continuum: Risk of Hospital-Associated Clostridium difficile Infection Due to Outpatient and Inpatient Antibiotic Exposure.
    Tartof SY; Rieg GK; Wei R; Tseng HF; Jacobsen SJ; Yu KC
    Infect Control Hosp Epidemiol; 2015 Dec; 36(12):1409-16. PubMed ID: 26387888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body mass index greater than 35 is associated with severe Clostridium difficile infection.
    Mulki R; Baumann AJ; Alnabelsi T; Sandhu N; Alhamshari Y; Wheeler DS; Perloff S; Katz PO
    Aliment Pharmacol Ther; 2017 Jan; 45(1):75-81. PubMed ID: 27790736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to: Surveillance of Clostridium difficile infections.
    Krutova M; Kinross P; Barbut F; Hajdu A; Wilcox MH; Kuijper EJ;
    Clin Microbiol Infect; 2018 May; 24(5):469-475. PubMed ID: 29274463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection.
    Thabit AK; Housman ST; Burnham CD; Nicolau DP
    J Hosp Infect; 2016 Feb; 92(2):167-72. PubMed ID: 26792686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium difficile in an Urban, University-Affiliated Long-Term Acute-Care Hospital.
    Jacob J; Wu J; Han J; Nelson DB
    Infect Control Hosp Epidemiol; 2017 Mar; 38(3):294-299. PubMed ID: 27923419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals.
    Zilberberg MD; Tabak YP; Sievert DM; Derby KG; Johannes RS; Sun X; McDonald LC
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):649-55. PubMed ID: 21666394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation to identify a resource-efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection.
    Chung P; Currie B; Guo Y; Talansky M; Brown S; Ostrowsky B
    Am J Infect Control; 2014 Oct; 42(10 Suppl):S264-8. PubMed ID: 25239720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. External Validation of Three Prediction Tools for Patients at Risk of a Complicated Course of Clostridium difficile Infection: Disappointing in an Outbreak Setting.
    van Beurden YH; Hensgens MPM; Dekkers OM; Le Cessie S; Mulder CJJ; Vandenbroucke-Grauls CMJE
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):897-905. PubMed ID: 28592343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent.
    Aitken SL; Alam MJ; Khaleduzzaman M; Walk ST; Musick WL; Pham VP; Christensen JL; Atmar RL; Xie Y; Garey KW
    Infect Control Hosp Epidemiol; 2015 Nov; 36(11):1318-23. PubMed ID: 26288985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospital Clostridium difficile infection (CDI) incidence as a risk factor for hospital-associated CDI.
    Miller AC; Polgreen LA; Cavanaugh JE; Polgreen PM
    Am J Infect Control; 2016 Jul; 44(7):825-9. PubMed ID: 26944007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk Factors that Predict Recurrent Clostridium difficile Infections in Surgical Patients.
    Messick CA; Hammel JP; Hull T
    Am Surg; 2017 Jun; 83(6):653-659. PubMed ID: 28637570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical predictors and risk factors for relapsing Clostridium difficile infection.
    Cadena J; Thompson GR; Patterson JE; Nakashima B; Owens A; Echevarria K; Mortensen EM
    Am J Med Sci; 2010 Apr; 339(4):350-5. PubMed ID: 20224312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions.
    Lambert PJ; Dyck M; Thompson LH; Hammond GW
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):945-51. PubMed ID: 19732008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection.
    Shaughnessy MK; Micielli RL; DePestel DD; Arndt J; Strachan CL; Welch KB; Chenoweth CE
    Infect Control Hosp Epidemiol; 2011 Mar; 32(3):201-6. PubMed ID: 21460503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical manifestations of Clostridium difficile infection in a medical center in Taiwan.
    Lai CC; Lin SH; Tan CK; Liao CH; Huang YT; Hsueh PR
    J Microbiol Immunol Infect; 2014 Dec; 47(6):491-6. PubMed ID: 23978490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and Risk Factors for Community and Hospital Acquisition of Clostridium difficile Infection in the Tel Aviv Sourasky Medical Center.
    Na'amnih W; Adler A; Miller-Roll T; Cohen D; Carmeli Y
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):912-920. PubMed ID: 28558856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.